AINewsnow

London AI drug discovery startup Boltz raises $110M Series A

This story is from 2026-11-19. It is preserved in the archive; the latest stories are on the live feed.

London-based AI drug discovery startup Boltz has raised a $110 million Series A funding round, less than a year after emerging from stealth. The company develops AI models to speed up drug discovery research.

Read the full story at Tech.eu ↗

Timeline · 1 report

  1. 2026-11-19 10:04 · Tech.eu
    London-based Boltz raises $110M Series A

More stories

  1. AI drug discovery startup Boltz raises $110M Series A — Techmeme
  2. Google launches Gemini 4 Neon mid-tier model and opens Genie 4 to Gemini API developers — Google DeepMind YouTube
  3. Anthropic begins trading in record IPO, shares surge on debut — Anthropic (X)
  4. Google books Blue Origin's New Glenn for 2029 launch of AI server satellites — Google: The Keyword
  5. AWS expands SageMaker JumpStart with OpenTSLM, model leaderboard, and PolyAI Dialog-RSN-1 — AWS Machine Learning Blog
  6. Nvidia scandal accelerates US AI chip export controls on China — NPR Technology
  7. Microsoft CEO warns AI-driven bug discovery is raising the pace of tech outages — OpenAI News
  8. ChatGPT, Claude, Gemini and Grok helped plan terror attacks in US government test — The Independent Tech

Read the Daily Brief: the day's most important AI stories →